Category: Oncology

Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation

Cell Medica, a leader in developing cellular immunotherapy for the treatment of cancer, today announced the U.S. Food and Drug Administration has granted Fast Track designation to its lead oncology product CMD-003 for patients with relapsed/refractory lymphoma and post-transplant lymphoproliferative disease associated with the oncogenic Epstein Barr virus . CMD-003, also known as baltaleucel-T, is an investigational therapy in which the patient’s T cells are activated to kill malignant cells expressing EBV antigens.

Bank funds cancer treatment*Feb. 19, 2017, 10:28 PM Ast

CHAT: Dr Curt Bodkyn, from right, paediatric oncologist lecturer/Unit Coordinator Child Health, The University of the West Indies Faculty of Medical Sciences, chats with Lisa Francis-Mc Carthy, administrator of RBC Children’s Cancer Fund, Trinidad and Tobago Cancer Society; Minister of Health Terrence Deyalsingh; and Gretchen Camacho-Mohammed, regional operating officer, RBC Royal Bank Trinidad & Tobago, during the tour of the Children’s Clinic of the Eric Williams Medical Sciences Complex where the RBC-donated Flow Cytometer will be housed.

Taking illness personally

This Thursday at 8 p.m., Dutt, 12, a will be featured on David Suzuki’s The Nature of Things on CBC for a cancer story. The 12-year-old student at Surrey’s Janice Churchill Elementary is part of a clinical trial at the BC Cancer Agency with some promising results that caught the eyes of producers.

Proton therapy for cancer coming to Alabama

UAB Hospital recently received approval to build a $50 million proton therapy center, which will be the first in the state to treat cancer patients with precise doses of radiation that reduce damage to normal tissue. The project has been in the works for years and just received approval from state health planning authorities.

Low-Fat Meal May Boost Costly Cancer Drug

… a month and patients typically remain on the drug for 12 to 18 months, researchers said. Even patients with the best health insurance can have co-pays of $1,000 to $3,000 a month. This study found similar outcomes between 36 advanced prostate cancer …

Few smokers seek CT scans to check for lung cancer

Few smokers seek CT scans to check for lung cancer Screening rates have barely budged in recent years Check out this story on thecalifornian.com: http://bit.ly/2lgSjYA In 2013, the U.S. Preventive Services Task Force recommended annual low-dose CT scans for many current or former smokers between the ages of 55 and 80. Under the health law, health plans have to cover preventive services recommended by the task force without charging consumers for them. Lung cancer screening rates have barely budged in recent years, according to a new study, even though under the health law many people don’t have to pay anything out-of-pocket for them because the test is recommended by a panel of prevention experts.

FLASCO to Host Educational Lunch Program on Living with Metastatic Breast Cancer

The Florida Society of Clinical Oncology will host a Living with Metastatic Breast Cancer Luncheon, an event to educate the public about metastatic cancer, this Wednesday, February 15, at 11:00 a.m. on the 22 floor of the Capitol Building . The event will include treatment and care-focused presentations from various cancer specialists from the Mayo Clinic Florida, Florida Cancer Specialists, and Tallahassee Memorial Cancer Center, as well as a Q&A session.

‘Death sentence not an option’ for Silsden cancer sufferer

A HUSBAND whose cancer-stricken wife was told to prepare for death in the UK has vowed to spend hundreds of thousands of pounds on radical treatment in Germany in a desperate bid to save her life. Doctors at Airedale Hospital sent in a palliative care team to ask how Sally Major, 33, wanted to spend her final few weeks but her husband Liam insisted “a death sentence was not an option”.

Communication in cancer care

Ask anyone about their experience with their own or a loved one’s cancer, and the response will likely include a story or remark about an oncologist, surgeon, nurse, or other health care provider. These are often positive stories: the oncologist who remembered a child’s birthday, the nurse who stayed after his shift to wait with an elderly patient until her daughter arrived to pick her up, or the surgeon who attended a husband’s funeral.

Beware! Dense breasts doubles risk of cancer: Study

Washington D.C. [USA], Feb. 10 : Beware! A study finds that women with dense breasts have two-fold increased risk of developing breast cancer. The study, published in the journal Cancer, is among the first to find the association between breast density and contralateral breast cancer .

TRACON Pharma Announces Top-Line Results From NCI-Sponsored Phase 2…

Combination of TRC105 and Avastin did not improve the median progression free survival versus single agent Avastin in recurrent glioblastoma patients Combination was associated with a non-significant increase in overall survival SAN DIEGO, Feb. 09, 2017 — TRACON Pharmaceuticals , a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration and fibrotic diseases, today reported top-line results from a randomized Phase 2 clinical trial of TRC105 in recurrent glioblastoma funded and conducted by the Clinical Therapy Evaluation Program of the National Cancer Institute .

NANOBIOTIX appoints senior executive from pharmaceutical industry, as Chief Operating Officer

Paris, France and Cambridge, Massachusetts, USA, February 7, 2017 – NANOBIOTIX , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced today the appointment of Alain Dostie, a senior executive from the pharmaceutical industry, as its Chief Operating Officer . Mr. Dostie will lead Nanobiotix’s operations, including development, manufacturing, market access and sales, for the Company’s lead product NBTXR3, which could obtain a CE Mark approval in 2017.

View Press Release

The Summit aims to showcase innovative organizations and how they are responding to changes occurring in the cancer care marketplace. “Today’s community oncology practices face many decisions and challenges, from new reimbursement structures to care models and technologies,” said Randy Hyun, senior vice president and general manager, Provider Solutions, McKesson Specialty Health.

Merck 2017 forecast eases concerns over royalty payments, dollar

Merck & Co Inc reported better-than-expected U.S. quarterly sales for its key cancer drug, Keytruda, and forecast largely in-line 2017 results, which some analysts said allayed concerns over the impact of a strong dollar and royalty payments. The logo of Merck is pictured in this illustration photograph in Cardiff, California April 26, 2016.

European researchers highlight potential of xenografts in cancer research and treatment

European research lays the foundation for the development of new and ambitious research projects with xenografts derived from patients, preclinical models with great potential to advance research and treatment in cancer. The review article, published in Nature Reviews Cancer , is the result of the joint work of the European consortium of researchers EurOPDX, which includes different researchers from the Bellvitge Biomedical Research Institute – Catalan Institute of Oncology , among which there are Eva Gonzalez-Suarez and Alberto Villanueva.